Although the therapeutic effect of PAT-BA4 has been limited in vitro, TAF15 targeting therapy has demonstrated anti-adhesion and anti-migration effects in cancer cells, which indicates the importance of TAF15 for increased malignant potential. This evidence concerns the gene TAF15 and cancer.